The effect of atypical and classical antipsychotics on sub-chronic PCP-induced cognitive deficits in a reversal-learning paradigm

Behavioural Brain Research

Volumn 169, Issue 2, 2006, Pages 263-273

  Abdul Monim, Z ^a   Reynolds, G P ^b   Neill, J C ^a  

^a UNIVERSITY OF BRADFORD   (United Kingdom)

^b QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

Author keywords

Atypical and classical antipsychotics; Cognition; Rat; Reversal learning; Schizophrenia; Sub chronic PCP

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; CHLORPROMAZINE; CLOZAPINE; DRUG VEHICLE; HALOPERIDOL; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NEUROLEPTIC AGENT; OLANZAPINE; PHENCYCLIDINE; ZIPRASIDONE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; FEMALE; FOOD INTAKE; LEARNING; MEDICAL ASSESSMENT; NONHUMAN; PRIORITY JOURNAL; RAT; SCHIZOPHRENIA;

ANALYSIS OF VARIANCE; ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; COGNITION DISORDERS; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; MALE; PHENCYCLIDINE; RATS; RECEPTORS, N-METHYL-D-ASPARTATE; REVERSAL LEARNING;

EID: 33645056175     PISSN: 01664328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbr.2006.01.019     Document Type: Article

References (52)

1. Z. Abdul-Monim, G.P. Reynolds, and J.C. Neill The atypical antipsychotic ziprasidone, but not haloperidol, improves PCP-induced cognitive deficits in a reversal-learning task J Psychopharmacol 17 2003 57 66
2. Z. Abdul-Monim, J.C. Neill, and G.P. Reynolds Sub-chronic PCP administration significantly alters parvalbumin-immunoreactive interneurones in the prefrontal cortex (PFC) and hippocampus of the rat Br Neurosci Assoc Abstr 17 2003 37.01
3. S. Akbarian, J.J. Kim, S.G. Potkin, J.O. Hagman, A. Tafazzoli, W.E. Bunney Jr, and E.G. Jones Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics Arch Gen Psychiatry 52 1995 258 266
4. C.A. Altar, A.M. Wasley, R.F. Neale, and G.A. Stone Typical and atypical antipsychotic occupancy of D2 and S2 receptors: an autoradiographic analysis in rat brain Brain Res Bull 16 1986 517 525
5. C. Beasley, Z. Zhang, I. Patten, and G.P. Reynolds Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins Biol Psychiatry 52 2002 708 715
6. C.L. Beasley, and G.P. Reynolds Parvalbumin-immunoreactive neurones are reduced in the prefrontal cortex of schizophrenia Schizophr Res 24 1997 349 355
7. F.M. Benes, and S. Berretta GABAergic interneurones: implications for understanding schizophrenia and bipolar disorder Neuropsychopharmacology 25 2001 1 27
8. F.M. Benes, J. McSparren, E.D. Bird, J.P. SanGiovanni, and S.L. Vincent Deficits in small interneurons in prefrontal and cingulated cortices of schizophrenic and schizoaffective patients Arch Gen Psychiatry 48 1991 996 1001
9. R.M. Bilder, R.S. Goldman, J. Volavka, P. Czobor, M. Hoptman, B. Sheitman, J.P. Lindenmayer, L. Citrome, J. McEvoy, M. Kunz, M. Chakos, T.B. Cooper, T.L. Horowitz, and J.A. Lieberman Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol in patients with chronic schizophrenia or schizoaffective disorder Am J Psychiatry 159 6 2002 1018 1028
10. D.L. Braff, R. Heaton, J. Kuck, M. Cullum, J. Moranville, I. Grant, and S. Zisook The generalized pattern of neuropsychological deficits in outpatients with chronic schizophrenia with heterogeneous Wisconsin card sorting test results Arch Gen Psychiatry 48 1991 891 898
11. S.M. Cochran, M. Fujimura, B.J. Morris, and J.A. Pratt Acute and delayed effects of phencyclidine upon mRNA levels of markers of glutamatergic and GABAergic neurotransmitter function in the rat brain Synapse 46 2002 206 214
12. S.M. Cochran, M. Kennedy, C.E. McKerchar, L.J. Steward, J.A. Pratt, and B.J. Morris Induction of metabolic hypofunction and neurochemical deficits after chronic intermittent exposure to phencyclidine: differential modulation by antipsychotic drugs Neuropsychopharmacology 28 2003 265 275
13. J. Cosgrove, and T.G. Newell Recovery of neuropsychological functions during reduction in use of phencyclidine J Clin Psychiatry 47 1991 159 169
14. A. Diamond, and P.S. Goldman-Rakic Comparison of human infants and rhesus monkeys on Piaget's A task: evidence for dependence on dorsolateral prefrontal cortex Exp Brain Res 74 1989 24 40
15. A.E. Evins, E.T. Amico, V. Shih, and D.C. Goff Clozapine treatment increases serum glutamate and aspartate compared to conventional neuroleptics J Neural Transm 104 1997 761 766
16. B. Gallhofer, U. Bauer, S. Lis, S. Krieger, and H. Gruppe Cognitive dysfunction in schizophrenia: comparison of treatment with atypical antipsychotic agents and conventional neuroleptic drugs Eur Neuropsychopharmacol 1996 S13 S20
17. B. Grayson, N.A. Leivers, and J.C. Neill Acute PCP does not affect novel object recognition in male hooded-Lister rats J Psychopharmacol 19 2005 A13
18. P.D. Harvey, and R.S. Keefe Studies of cognitive change in patients with schizophrenia following novel antipsychotic treatment Am J Psychiatry 158 2001 176 184
19. D. Honack, and W. Loscher Sex differences in NMDA receptor mediated responses in rats Brain Res 620 1993 167 170
20. N.F. Idris, C.H. Large, G.P. Reynolds, and J.C. Neill Lamotrigine and clozapine reverse an established cognitive deficit induced by sub-chronic PCP (phencyclidine) in the rat Br J Pharmacol 1 3 2004 056 (PA2 online)
21. N.F. Idris, P. Repeto, J.C. Neill, and C.H. Large Investigation of the effects of lamotrigine and clozapine to improve reversal-learning impairments induced by acute PCP and d-amphetamine in the rat Psychopharmacology 179 2005 336 348
22. J.D. Jentsch, and R.H. Roth The neuropsychopharmacology of phencyclidine: from NMDA receptor hypofunction to the dopamine hypothesis of schizophrenia Neuropsychopharmacology 20 1999 201 225
23. J.D. Jentsch, L. Dazzi, J.P. Chhatwal, C.D. Verrico, and R.H. Roth Reduced prefrontal cortical dopamine, but not acetylcholine, release in vivo after repeated, intermittent phencyclidine administration to rats Neurosci Lett 258 1998 175 178
24. J.D. Jentsch, D.E. Redmond, J.D. Elsworth, J.R. Taylor, K.D. Younren, and R.H. Roth Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after long-term administration of phencyclidine Science 277 1997 953 955
25. J.D. Jentsch, A. Tran, D. Le, K.D. Youngren, and R.H. Roth Sub-chronic phencyclidine administration reduces mesoprefrontal dopamine utilization and impairs prefrontal cortical-dependent cognition in the rat Neuropsychopharmacology 17 1997 92 99
26. K.M. Johnson, M. Phillips, C. Wang, and G.A. Kevetter Chronic phencyclidine induces behavioral sensitization and apoptotic cell death in the olfactory and piriform cortex J. Neurosci Res 52 1998 709 722
27. G.H. Jones, C.A. Marsden, and T.W. Robbins Behavioural rigidity and rule-learning deficits following isolation-rearing in the rat: neurochemical correlates Behav Brain Res 43 1991 35 50
28. S. Kapur, and G. Remington Dopamine D2 receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient Biol Psychiatry 50 2001 873 883
29. S. Kapur, and P. Seeman Does fast dissociation from the dopamine D2 receptors explain atypical antipsychotic action - new hypothesis Am J Psychiatry 158 2001 360 369
30. S. Kapur, S.C. Vanderspek, B.A. Brownlee, and J.N. Nobrega Antipsychotic dosing in preclinical models is often unrepresentative of the clinical condition: a suggested solution based on in vivo occupancy J Pharmacol Exp Ther 305 2003 625 631
31. M.B. Knable, and Weinberger DR Dopamine, the prefrontal cortex and schizophrenia Psychopharmacology 11 1997 123 131
32. Lewis JE, Hordan RB. In: Peterson RC, Stillman RC, editors. Phencyclidine: an update. National Institute on Drug Abuse Res Monogr.
33. T. Ljubin, D. Zakic Milas, N. Mimica, V. Folnegovic-Smalc, and G. Makaric A preliminary study of the comparative effects of olanzapine and fluphenazine on cognition in schizophrenic patients Hum. Psychopharmacol 15 2000 513 519
34. J.W. Olney, J.W. Newcomer, and N.B. Farber NMDA receptor hypofunction model of schizophrenia J Psychiatr Res 33 1999 523 533
35. S.E. Purdon Cognitive improvement in schizophrenia with novel antipsychotic medication Schizophr Res 35 1999 51 60
36. S.E. Purdon, A. Malla, A. Labelle, and W. Lit Neuropsychological change in patients with schizophrenia after treatment with quetiapine or haloperidol J Psychiatr Neurosci 26 2001 137 149
37. G.P. Reynolds, Z. Abdul-Monim, J.C. Neill, and Z.J. Zhang Calcium binding protein markers of GABA deficits in schizophrenia-post-mortem studies and animal models Neurotoxicity 6 2004 57 61
38. 2A receptor antagonist, MDL100907, increase dopamine efflux in the prefrontal cortex of the rat Eur J Pharmacol 273 1995 273 279
39. U. Schroeder, H. Schroeder, H. Schwegler, and B.A. Sabel Neuroleptics ameliorate phencyclidine-induced impairments of short-term memory Br J Pharmacol 130 1 2000 33 40
40. T. Sharma, and D. Mockler The cognitive efficacy of atypical antipsychotics in schizophrenia J Clin Psychopharmacol 18 1998 12S 19S
41. R.C. Smith, M. Infante, A. Singh, and A. Khandat The effects of olanzapine on neurocognitive functioning in medication-refractory schizophrenia Int J Neuropsychopharmacol 4 2001 239 250
42. M.R. Stefani, and Moghaddam B Effects of repeated treatment with amphetamine or phencyclidine on working memory in the rat Behav Brain Res 134 2002 267 274
43. R.E. Steinpreis The behavioural and neurochemical effects of phencyclidine in humans and animals: some implications for modelling psychosis Behav Brain Res 74 1996 45 55
44. N.R. Swerdlow, V. Bakshi, M. Waikar, N. Taaid, and M.A. Geyer Seroquel, clozapine and chlorpromazine restore sensorimotor gating in ketamine-treated rats Psychopharmacology 140 1998 75 80
45. F. Tascedda, J.M. Blom, N. Brunello, K. Zolin, M. Gennarelli, A. Colzi, D. Bravi, S. Carra, G. Racagni, and M.A. Riva Modulation of glutamate receptors in response to the novel antipsychotic olanzapine in rats Biol Psychiatry 50 2001 117 122
46. J.R. Taylor, R.H. Roth, J.R. Sladek Jr, and D.E. Redmond Jr Cognitive and motor deficits in the performance of an object retrieval task with a barrier-detour in monkeys (Cercopithecus aethiops sabaeus) treated with MPTP: long-term performance and effect of transparency of the barrier Behav Neurosci 104 1990 564 576
47. D.R. Weinberger, K.F. Berman, and B.P. Illowsky Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. III. A new cohort and evidence of a monoaminergic mechanism Arch Gen Psychiatry 45 1988 609 615
48. X. Xu, and E.F. Domino Phencyclidine-induced behavioural sensitization Pharmacol Biochem Behav 47 1994 603 608
49. S. Yamada, M. Harano, N. Annoh, K. Nakamura, and M. Tanaka Involvement of serotonin 2A receptors in phencyclidine-induced disruption of prepulse inhibition of the acoustic startle in rats Biol Psychiatry 46 1999 832 838
50. Z.J. Zhang, and G.P. Reynolds A selective decrease in the relative density of parvalbumin-immunoreactive interneurons in the hippocampus in schizophrenia Schizophr Res 55 2002 1 10
51. S. Castellani, and P.M. Adams Acute and sub-chronic PCP effects on locomotor activity, stereotypy and ataxia in the rat Eur J Pharmacol 73 1981 143 154
52. R.D. Sturgeon, R.G. Fessler, S.F. London, and H.Y. Meltzer Behavioural effects of chronic phenyclidine administration in rats Psychopharmacology 76 1982 52 56